中文名：Cerdulatinib 盐酸盐
英文名：Cerdulatinib hydrochloride
英文别名：1369761-01-2|Cerdulatinib hydrochloride|Cerdulatinib HCl|Cerdulatinib HCl salt|RVT-502 hydrochloride|Cerdulatinib (hydrochloride)|L1KRM66Y4X|4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide;hydrochloride|PRT2070|Ce
纯度：98%
货号：C413796
包装：10mg、200mg、50mg
Cas号：1369761-01-2
存储温度：-20°C储存
产品介绍：
产品介绍：
Cerdulatinib hydrochloride 是一种选择性可逆，具有口服活性、 ATP 竞争性的Syk和JAK的双重抑制剂，它可用于研究自身免疫性疾病和B细胞恶性肿瘤。
激酶实验：Purified Kinase Assays: Potency against purified SYK is determined by fluorescence resonance energy transfer. A broader panel of 270 purified kinases is surveyed in which PRT062070 is tested at a fixed concentration of 300 nM. [33P]-labeled substrate is measured after incubation of purified kinase with peptide substrate and [33P]ATP at the Km concentration for the kinase.
细胞实验：Cell lines (Ramos RA-1, Daudi, Toledo, SU-DHL4 and SU-DHL6) are cultured in RPMI media supplemented with 10% fetal bovine serum. Cells are treated with the indicated concentrations of PRT062070, the SYK-selective inhibitor PRT060318, the pan-JAK inhibitor 1, a 1:1 combination of PRT060318 and JAK inhibitor 1, or vehicle control (0.5% dimethylsulfoxide) for 72 hours. Cell viability assays are performed using CellTiter Glo in 384-well plates. Cells are seeded at a density of 5000 cells per well. (Only for Reference)
查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/C413796.html
关键字： 1369761-01-2;Cerdulatinib hydrochloride;Cerdulatinib HCl;Cerdulatinib HCl salt
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代码：688179），专注于科研试剂的研发、生产和销售，已陆续建立多个工厂和研发中心。作为领军企业，阿拉丁始终坚持质量第一，连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种，SKU总数超过46万，产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域，是国内少数化学试剂到生物试剂全面发展的国产试剂品牌，产品同步发布在我们国内外电商平台。